PMID- 26495134 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20151023 LR - 20240325 IS - 2090-004X (Print) IS - 2090-0058 (Electronic) IS - 2090-004X (Linking) VI - 2015 DP - 2015 TI - Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma. PG - 131970 LID - 10.1155/2015/131970 [doi] LID - 131970 AB - Purpose. To evaluate the safety and efficacy of adding brinzolamide 1%/timolol maleate 0.5% fixed combination (BTFC) to a prostaglandin analog (PGA). Methods. This was a 12-week, open-label, single-arm study of patients with open-angle glaucoma or ocular hypertension with intraocular pressure (IOP) not sufficiently controlled after >/=4 weeks of PGA monotherapy. The primary outcome was mean IOP change from baseline at week 12. Other outcomes included IOP change from baseline at week 4, percentage of patients achieving IOP